An executive from Pharmaceutical Associates Inc. believes bringing drug manufacturing back to the country will help avoid shortages and other disasters.
The company’s Sandoz division is offering 15 generic and OTC medicines to be sold at zero profit to low- and middle-income countries to treat the virus.
The agency continues to offer advice to pharma industry professionals during the global public health crisis, and offer advice on developing solutions.
The clinical trial site network company's survey of participants offers information that could shed light on ways to improve recruitment and retention.
The two companies will work together to promote technology for at-home clinical research conducted in trials focused on developing respiratory therapies.
After receiving FDA approval, the pharmaceutical company has announced plans to launch a Phase I trial for an inhaled version of the COVID-19 treatment.
The CDMO has landed a grant from the Bill and Melinda Gates Foundation’s COVID-19 Therapeutics Accelerator for clinical research in the sub-Saharan region.
The federal agency continues to aid drug developers, trial teams and the public with advice and actions related to the virus behind the global pandemic.
A comprehensive dive into the contract research organization field offers a glimpse into how the virus has affected firms, and what the future might hold.
A leader from the contract research organization explains how home health personnel, decentralized trial technology and other services can help avoid study interruptions
The agency continues to offer advice related to drug development and clinical research during the pandemic, and take action against those falling out of line.
A leader from the clinical development services firm recommends clinical trials change their tack to avoid costly clinical trial interruptions in the face of the pandemic.
The clinical trial company launched the trial around cytokine storm, an immunological reaction associated with severe virus cases, in 15 business days.
The federal agency continues to monitor as the virus impacts the pharma and clinical trials industries, offering advice and taking action where necessary.
The healthcare institution and life-sciences technology platform are working together to use artificial intelligence to detect and understand the virus.
The open-access resource, funded in part by the Bill and Melinda gates Foundation, is available to researchers, clinicians and others working on a cure.
